Profile cover photo
Profile photo
Healthegy Inc.
15 followers -
Uniting the people who know, to talk about the things that matter.
Uniting the people who know, to talk about the things that matter.

15 followers
About
Healthegy Inc.'s posts

Post has attachment
Dr. Le knows people will need to kick the Google habit. To do that, Buoy will work with health plans and providers to build trust and drive people to use the product so they get a more personalized view of their health.

To learn more, listen to this Breaking Health podcast:

Post has attachment
With patients paying more out of pocket, consumers will become a more powerful force in healthcare, says Steve Kraus, partner at Bessemer Venture Partners.

Watch this interview to learn more:

Post has attachment
Michael Mahoney, Chairman and CEO of Boston Scientific, recalled his decision to join the company at its recent lowpoint. What’s happened since?

Watch this Medtech Conference 2017 video to learn more:

Post has attachment
After capturing lighting in a bottle with Oculeve, Ali Behbahani, MD, partner of New Enterprise Associates, recalls the experience with the Dry Eye start-up and lays out his plans for investing in future ophthalmology start-ups.

Listen to this OIS Podcast to learn more:

Post has attachment
Omada Health, Inc. is trying to pull people back from the brink of diabetes. The company’s social tool brings at-risk patients together to lose weight and improve their health overall.

To learn more, watch this interview with Sean Duffy:

Post has attachment
Hear how Omada CEO Sean Duffy is building a DigitalRx Leader.

Post has attachment
Max G. Ostermeier, MBA, co-founder and general manager of Implandata Ophthalmic Products GmbH, charts a course for the company after securing CE mark for its EYEMATE eye pressure measurement system for continuous measurement of IOL in patients with glaucoma.

Post has attachment
New Enterprise Associates – known to its friends as NEA – announced closing on a $3.3 billion venture capital fund, with roughly 10% of that total going to Medtech companies.

Post has attachment
Now that the Implandata Ophthalmic Products has received approval to commercialize its implantable glaucoma-monitoring device in the European Union, it’s setting its sights on lining up funding to launch US trials in 2018.

Post has attachment
With GE changing hands at the CEO level, let’s look back to this Digital Healthcare Innovation Summit conversation with Charles Koontz, president and CEO of GE Healthcare IT, and chief digital officer for GE Healthcare.
Wait while more posts are being loaded